BMO Capital Reiterates Outperform Rating on 4D Molecular Therapeutics (FDMT)

Go back to BMO Capital Reiterates Outperform Rating on 4D Molecular Therapeutics (FDMT)
(NASDAQ: FDMT) Delayed: 12.19 +0.54 (4.64%)
Previous Close $11.65    52 Week High
Open $11.63    52 Week Low
Day High $12.35    P/E N/A 
Day Low $11.26    EPS
Volume 773,765